{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:06:01Z","timestamp":1790863561849,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Methicillin resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA) is a major contributor to the global burden of antimicrobial resistance (AMR). As MRSA continues to evolve, the need for continued surveillance to evaluate trends remains crucial. This study was carried out to assess MRSA trends in the United Arab Emirates (UAE) based on analysis of data from the national AMR surveillance program.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We carried out a 12-year (2010\u20132021) retrospective analysis of MRSA demographic and microbiological data collected as part of the UAE national AMR surveillance program. Participating centers from across the country routinely submit AMR surveillance data collected by trained personnel to the National AMR Surveillance Committee, where data is analyzed using a unified WHONET platform. Data on non-duplicate isolates associated with clinical infections were obtained and included in the analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 29,414 non-duplicate MRSA isolates associated with clinical infections were reported between 2010 and 2021 (2010: <jats:italic>n<\/jats:italic> = 259; 2021: <jats:italic>n<\/jats:italic> = 4,996). MRSA represented 26.4% of all <jats:italic>S. aureus<\/jats:italic> (<jats:italic>n<\/jats:italic> = 111,623) isolates identified during the study period. In 2010, among the <jats:italic>S. aureus<\/jats:italic> isolates with reported oxacillin testing, 21.9% (<jats:italic>n<\/jats:italic>\/<jats:italic>N<\/jats:italic> = 259\/1,181) were identified as MRSA and this showed an increase to 33.5% (<jats:italic>n<\/jats:italic>\/<jats:italic>N<\/jats:italic> = 4,996\/14,925) in 2021. Although there was variation in the distribution of MRSA across the seven emirates of the country, most had an upward trend. Patient demographics reflected a male preponderance, with most being adults and from the outpatient setting. Isolates were mostly from skin and soft tissue infection specimens (72.5%; <jats:italic>n<\/jats:italic>\/<jats:italic>N<\/jats:italic> = 21,335\/29,414). Among the inpatients (<jats:italic>N<\/jats:italic> = 8,282), a total of 3,313 MRSA isolates were from specimens obtained \u2264 48 h after admission indicative of community acquired infection. Increasing resistance trends were observed for most antibiotics including ciprofloxacin, levofloxacin, moxifloxacin, erythromycin, gentamicin, trimethoprim-sulfamethoxazole, and quinupristin\/dalfopristin. Low levels of resistance (0.0\u20130.8%) were sustained for linezolid except for 2015, 2016, and 2017 with 2.5, 2.6, and 2.9%, respectively. No confirmed vancomycin resistance was reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The increasing trend of MRSA isolates associated with clinical infections in the hospital and community settings is a concern. Continued monitoring including incorporation of genomic surveillance and infection control measures are recommended to stem the dissemination.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1244351","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T15:25:41Z","timestamp":1701962741000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Methicillin resistant Staphylococcus aureus in the United Arab Emirates: a 12-year retrospective analysis of evolving trends"],"prefix":"10.3389","volume":"11","author":[{"given":"Jens","family":"Thomsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najiba M.","family":"Abdulrazzaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The UAE AMR Surveillance Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfred Antony","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Ayoub Moubareck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean B.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiola","family":"Senok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"B1","year":"2016","journal-title":"Tackling Drug Resistant Infections Globally: Final Report and Recommendations"},{"key":"B2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jiph.2021.02.011","article-title":"Antimicrobial resistance threats in the emerging COVID-19 pandemic: where do we stand?","volume":"14","author":"Ghosh","year":"2021","journal-title":"J Infect Public Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2147\/IDR.S314029","article-title":"Coinfections in patients hospitalized with COVID-19: a descriptive study from the United Arab Emirates","volume":"14","author":"Senok","year":"2021","journal-title":"Infect Drug Resist"},{"key":"B4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/156652409787581637","article-title":"The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus","volume":"9","author":"Deurenberg","year":"2009","journal-title":"Curr Mol Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.mib.2012.08.003","article-title":"Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA)","volume":"15","author":"Mediavilla","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12873-018-0164-7","article-title":"Methicillin resistant Staphylococcus aureus in emergency department patients in the United Arab Emirates","volume":"18","author":"Al Jalaf","year":"2018","journal-title":"BMC Emerg Med"},{"key":"B8","unstructured":"LondonTackling a Crisis for the Health Wealth of nations2014"},{"key":"B9","doi-asserted-by":"publisher","first-page":"18551","DOI":"10.1038\/s41598-020-75565-w","article-title":"Genotyping of methicillin resistant Staphylococcus aureus from the United Arab Emirates","volume":"10","author":"Senok","year":"2020","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1089\/mdr.2019.0318","article-title":"Molecular characterization of Staphylococcus aureus isolates associated with nasal colonization and environmental contamination in academic dental clinics","volume":"26","author":"Senok","year":"2020","journal-title":"Microb Drug Resist"},{"key":"B11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/jclinpath-2011-200436","article-title":"Change in meticillin-resistant Staphylococcus aureus clones at a tertiary care hospital in the United Arab Emirates over a 5-year period","volume":"65","author":"Sonnevend","year":"2012","journal-title":"J Clin Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1247627","DOI":"10.3389\/fpubh.2023.124762","article-title":"Surveillance of antimicrobial resistance in the United Emirates: the early implementation phase","volume":"11","author":"Thomsen JT","year":"2023","journal-title":"Front Public Health."},{"key":"B13","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing, 24th Informational Supplement (M100-S24)","year":"2014"},{"key":"B14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.26719\/emhj.22.042","article-title":"Trends in methicillin-resistant Staphylococcus aureus in the Gulf Cooperation Council countries: antibiotic resistance, virulence factors and emerging strains","volume":"28","author":"Al-Saleh","year":"2022","journal-title":"East Mediterr Health J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1001\/jamainternmed.2013.10423","article-title":"National Burden of Invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011","volume":"173","author":"Dantes","year":"2013","journal-title":"JAMA Int Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/1469-0691.12028","article-title":"The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System","volume":"19","author":"de Kraker","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/pathogens10081000","article-title":"Ecology and genetic lineages of nasal Staphylococcus aureus and MRSA carriage in healthy persons with or without animal-related occupational risks of colonization: a review of global reports","author":"Abdullahi","year":"2021","journal-title":"Pathogens"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0179767","DOI":"10.1371\/journal.pone.0179767","article-title":"Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: retrospective database study of Japanese hospitals","volume":"12","author":"Uematsu","year":"2017","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/14787210.2016.1236684","article-title":"Changing epidemiology of community-associated methicillin-resistant Staphylococcus aureus in the Asia-Pacific region","volume":"14","author":"Huh","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ijmm.2013.02.007","article-title":"Community-associated MRSA: what makes them special?","volume":"303","author":"Otto","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1128\/CMR.00081-09","article-title":"Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic","volume":"23","author":"David","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MAJ.0b013e3181e95fdc","article-title":"Increasing threat of community-acquired methicillin-resistant Staphylococcus aureus","volume":"340","author":"Bukharie","year":"2010","journal-title":"Am J Med Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0162744","DOI":"10.1371\/journal.pone.0162744","article-title":"Shifts in the clonal distribution of methicillin-resistant Staphylococcus aureus in Kuwait hospitals: 1992-2010","volume":"11","author":"Boswihi","year":"2016","journal-title":"PLoS ONE"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/nmi2.47","article-title":"Genotyping of methicillin-resistant Staphylococcus aureus in the Sultan Qaboos University Hospital, Oman reveals the dominance of Panton-Valentine leucocidin-negative ST6-IV\/t304 clone","volume":"2","author":"Udo","year":"2014","journal-title":"N Microbes New Infect"},{"key":"B26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nmni.2016.07.009","article-title":"Molecular characterization of methicillin-resistant Staphylococcus aureus in nosocomial infections in a tertiary-care facility: emergence of new clonal complexes in Saudi Arabia","volume":"14","author":"Senok","year":"2016","journal-title":"N Microbes New Infect"},{"key":"B27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/1469-0691.12240","article-title":"Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients","volume":"20","author":"El-Mahdy","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.2147\/IDR.S218870","article-title":"Emergence of novel methicillin-resistant Staphylococcus aureus strains in a tertiary care facility in Riyadh, Saudi Arabia","volume":"12","author":"Senok","year":"2019","journal-title":"Infect Drug Resist"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0195933","DOI":"10.1371\/journal.pone.0195933","article-title":"Emerging variants of methicillin-resistant Staphylococcus aureus genotypes in Kuwait hospitals","volume":"13","author":"Boswihi","year":"2018","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"754523","DOI":"10.3389\/fcimb.2021.754523","article-title":"Lateral flow immunoassay for the detection of panton-valentine leukocidin in Staphylococcus aureus from skin and soft tissue infections in the United Arab Emirates","volume":"11","author":"Senok","year":"2021","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1244351\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T15:25:46Z","timestamp":1701962746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1244351\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":30,"alternative-id":["10.3389\/fpubh.2023.1244351"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1244351","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"article-number":"1244351"}}